Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Carson

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|November 29, 2007
Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapyKazuhiko Kurozumi, Jayson Hardcastle, Roopa Thakur, et al.
Research Square|February 26, 2024
Allostatic Load as a Predictor of Postoperative Complications in Patients with Breast CancerSamilia Obeng-Gyasi, J C Chen, Mohamed Elsaid, et al.
Neuropsychiatric Disease and Treatment|June 10, 2011
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorderRobert M Berman, Michael E Thase, Madhukar H Trivedi, et al.
Psycho-Oncology|April 9, 2025
Combined Treatment With Cognitive Behavioral Therapy for Insomnia and Acceptance and Commitment Therapy Enhances Objective and Subjective Reports of Sleep in Patients With Advanced CancerSharla Wells-Di Gregorio, Stacy Flowers, Juan Peng, et al.
Pharmacoepidemiology and Drug Safety|October 7, 2010
Epidemiologic study of aripiprazole use and the incidence of suicide eventsMarianne Ulcickas Yood, Gerald Delorenze, Charles P Quesenberry, et al.
Oncoimmunology|October 21, 2016
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activatorPrashant Trikha, Robert L Plews, Andrew Stiff, et al.
International Journal of Radiation Oncology, Biology, Physics|December 8, 2025
Use of Magnetic Resonance Imaging to Guide Preoperative Accelerated Partial Breast Irradiation in the Prone Position and Treatment Response in Clinical Stage 1 Hormone Sensitive Breast Cancer: A Phase 1/2 StudySasha Beyer, Jeffrey Hawley, Yevgeniya Gokun, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2024
Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid CancerBhavana Konda, Eric J Sherman, Erminia Massarelli, et al.
Investigational New Drugs|January 19, 2020
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Mohamed Badawi, Ewa Mrozek, et al.
Frontiers in Research Metrics and Analytics|November 30, 2023
Indigenous Peoples and research: self-determination in research governanceIbrahim Garba, Rogena Sterling, Rebecca Plevel, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|November 29, 2007
Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapyKazuhiko Kurozumi, Jayson Hardcastle, Roopa Thakur, et al.
Research Square|February 26, 2024
Allostatic Load as a Predictor of Postoperative Complications in Patients with Breast CancerSamilia Obeng-Gyasi, J C Chen, Mohamed Elsaid, et al.
Neuropsychiatric Disease and Treatment|June 10, 2011
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorderRobert M Berman, Michael E Thase, Madhukar H Trivedi, et al.
Psycho-Oncology|April 9, 2025
Combined Treatment With Cognitive Behavioral Therapy for Insomnia and Acceptance and Commitment Therapy Enhances Objective and Subjective Reports of Sleep in Patients With Advanced CancerSharla Wells-Di Gregorio, Stacy Flowers, Juan Peng, et al.
Pharmacoepidemiology and Drug Safety|October 7, 2010
Epidemiologic study of aripiprazole use and the incidence of suicide eventsMarianne Ulcickas Yood, Gerald Delorenze, Charles P Quesenberry, et al.
Oncoimmunology|October 21, 2016
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activatorPrashant Trikha, Robert L Plews, Andrew Stiff, et al.
International Journal of Radiation Oncology, Biology, Physics|December 8, 2025
Use of Magnetic Resonance Imaging to Guide Preoperative Accelerated Partial Breast Irradiation in the Prone Position and Treatment Response in Clinical Stage 1 Hormone Sensitive Breast Cancer: A Phase 1/2 StudySasha Beyer, Jeffrey Hawley, Yevgeniya Gokun, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2024
Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid CancerBhavana Konda, Eric J Sherman, Erminia Massarelli, et al.
Investigational New Drugs|January 19, 2020
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Mohamed Badawi, Ewa Mrozek, et al.
Frontiers in Research Metrics and Analytics|November 30, 2023
Indigenous Peoples and research: self-determination in research governanceIbrahim Garba, Rogena Sterling, Rebecca Plevel, et al.
Pageof 5